In March 2025, the National Institute of Allergy and Infectious Diseases (NIAID) began soliciting comments on the future of the four Division of AIDS (DAIDS)-sponsored HIV clinical research networks: ACTG, IMPAACT, HPTN, and HVTN.
TAG’s annual Research in Action Awards is our most anticipated night of the year.
Treatment Action Group and ANEA Coalition strongly condemn the House Labor, Health and Human Services proposed $2 billion in federal cuts to domestic HIV programs, including plans that would dismantle the CDC’s Division of HIV Prevention and slash $535 million from the Ryan White HIV/AIDS Program.
A global coalition reacted to two deals announced today to make long acting lenacapavir (LEN-LA), a 6 monthly HIV PrEP (pre-exposure prophylaxis) injection that provides virtually 100% protection against HIV infection, at $40 per person per year in 2027.
TAG letter urging the Advisory Committee on Immunization Practices (ACIP) to maintain the recommendation of a universal hepatitis B virus (HBV) birth dose vaccine in the United States.
On Sept. 3 20+ organizations — including TAG — signed this Infectious Diseases Society of America’s (IDSA) joint statement calling for the resignation of Sec. Robert F. Kennedy Jr. The letter outlines the many ways Kennedy’s “agenda” is meant to undermine science and public health.
The current administration’s Executive Order on Ending Crime and Disorder on America’s streets is yet another direct attack on science and basic human rights.
The Trump Administration plan to end PEPFAR (the President's Emergency Plan for AIDS Relief) was leaked yesterday to the New York Times which had damning information about Secretary Rubio proposing a swift end to the program.
The World Health Organization (WHO) guidelines for diagnosing TB have evolved along with available technologies and tools that are increasingly accurate, simple, and efficient at detecting TB and resistance to a wider range of TB drugs.